CD8A and neoplasm: Tumor-associated macrophages directly inhibit immune checkpoint inhibitor responses by removing anti-PD-1 antibodies from PD-1+ CD8+ T cells in an FcγR-dependent manner (Garris et al., 2018; Chen et al., 2019).